Plant Bio Technologies SA
0.3 FTEPlant Bio Technologies reported total assets of €1.04m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026), with 0.3 full-time equivalent.
The score of Plant Bio Technologies shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -3 % Total assets +51 % Headcount (avg FTE) -62 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Plant Bio Technologies's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 29 Jul 2025
- Year ended 31 Dec 2023filed on 31 Jul 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Plant Bio Technologies's financial analysis
- Solvency23.0%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Plant Bio Technologies
Plant Bio Technologies's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0537.556.083
- VAT number
- BE0537556083
- Peppol
- Registered · 0208:0537556083 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 20 Aug 2013
- Registered office
- 9051 Ghent
- Size
- Micro · 0.3 FTE
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Plant Bio Technologies (SA) has been based in Ghent since 2013, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net loss of 29,896 € and equity of 239,880 €; its revenue is not published. With 0.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 23.0%, below the median of its sector (56.0%).
Companies similar to Plant Bio Technologies
Companies in the same business, of comparable size and area, outside its group.
- Galenicap Manufacture of basic pharmaceutical products Ixelles · balance sheet €1.47m
- OLYS Pharma Manufacture of pharmaceutical preparations La Hulpe · balance sheet €1.03m
- Pharma Chemicals France Manufacture of basic pharmaceutical products Braine-le-Château · balance sheet €1.08m
- GRNR Invest Manufacture of basic pharmaceutical products Zemst · balance sheet €2.26m
- Equibor Manufacture of basic pharmaceutical products Manage · balance sheet €1.12m
- Shant Laboratories Belgium Manufacture of basic pharmaceutical products Tubize · balance sheet €1.06m
- XeroThera Europe Manufacture of basic pharmaceutical products Liège · balance sheet 820,359 €
- DeuterOncology Manufacture of basic pharmaceutical products Liège · balance sheet 688,028 €
Frequently asked questions about Plant Bio Technologies
What is the revenue of Plant Bio Technologies?
Plant Bio Technologies files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Plant Bio Technologies?
In Belgium, the VAT number is the company number prefixed with BE: BE0537556083 for Plant Bio Technologies, if the company is VAT-registered. Its company number (CBE) is 0537.556.083.
Where is the registered office of Plant Bio Technologies?
According to the CBE register, the registered office of Plant Bio Technologies is in 9051 Ghent.
What is the equity of Plant Bio Technologies?
At the close of the 2025 financial year, the equity of Plant Bio Technologies amounts to 239,880 €, a solvency of 23.0% of total assets.
How many people work at Plant Bio Technologies?
0.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Plant Bio Technologies?
The register lists 4 active mandates at Plant Bio Technologies. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Plant Bio Technologies
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →